Familial aggregation rate of psoriasis in pediatric rheumatic diseases: A tertiary center cross-sectional study and insights into shared autoimmune pathways
Trends in Pediatrics · 30.06.2026 · 7 (2) · 129-136
DOI: 10.59213/tp.2026.411 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Trends in Pediatrics, online erschienen am 30.06.2026. Verfasst von Elif Kılıç Könte und 14 weiteren Autor:innen. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The coexistence of psoriasis and juvenile‑onset systemic lupus erythematosus (jSLE) is rare, and data on familial aggregation of psoriasis across pediatric rheumatic diseases are limited. This study evaluated the co-existence of psoriasis in jSLE, its familial clustering, and its association with the jSLE phenotype.
Methods
In this single‑center cross‑sectional study, patients with jSLE, familial Mediterranean fever (FMF), and juvenile systemic sclerosis (jSSc) were systematically screened for personal and family histories of psoriasis. Recurrence risk ratios for psoriasis were calculated separately for patients and their relatives within each disease group. Among patients with jSLE, clinical manifestations, laboratory parameters, and disease activity (SLEDAI‑2K) were compared between those with and without personal and/or familial psoriasis.
Results
Of 189 patients with pediatric rheumatic diseases included, 94 (49.7%) had jSLE, 73 (38.6%) had FMF, and 22 (11.7%) had jSSc; 69.3% were female, with a higher frequency in jSLE patients (85.1%). Overall, 7,034 individuals (patients and relatives) were systematically screened for psoriasis. Psoriasis was identified in 4 patients (2.1%), all with jSLE (4.3%), and in 25 relatives (0.36%), yielding an overall prevalence of 0.41%. The combined prevalence of psoriasis in jSLE patients and their relatives (0.54%) was significantly higher than in FMF (0.35%) and jSSc (0%) families (p = 0.034). Recurrence risk ratios (λ) for psoriasis in jSLE families were 10.13 for patients and 3.07, 1.16, and 0.67 for first‑, second‑, and third‑degree relatives, respectively; corresponding λ values in FMF families were 0, 1.88, 1.11, and 0.45. Among 94 patients with jSLE, 20 had a personal or family history of psoriasis. However, their clinical signs, laboratory results, and SLEDAI-2K scores showed no significant differences compared with those without a history of psoriasis (p > 0.05).
Conclusion
A positive family history of psoriasis is more common in jSLE than in FMF or jSSc, supporting the hypothesis of a shared genetic background between psoriasis and jSLE, but it was not associated with more severe jSLE in this cohort. These findings underscore the importance of routinely assessing familial psoriasis in jSLE and related disorders and warrant confirmation in larger, prospective, population‑based studies.
Zitieren
APA
Könte, E. K., Şimşek, G. E., Uçak, K., Torunoğlu, Z., Aslan, E., Akay, N., Gül, Ü., Aslan, E., Günalp, A., Haşlak, F., Yıldız, M., Adroviç, A., Şahin, S., Barut, K., & Kasapçopur, Ö. (2026). Familial aggregation rate of psoriasis in pediatric rheumatic diseases: A tertiary center cross-sectional study and insights into shared autoimmune pathways. Trends in Pediatrics, 7(2), 129-136. https://doi.org/10.59213/tp.2026.411
Vancouver
Könte EK, Şimşek GE, Uçak K, Torunoğlu Z, Aslan E, Akay N, et al. Familial aggregation rate of psoriasis in pediatric rheumatic diseases: A tertiary center cross-sectional study and insights into shared autoimmune pathways. Trends in Pediatrics. 2026;7(2):129-136. doi:10.59213/tp.2026.411
BibTeX
@article{Knte2026,
author = {Könte, Elif Kılıç and Şimşek, Gülesser Eylül and Uçak, Kübra and Torunoğlu, Zeynep and Aslan, Ece and Akay, Nergis and Gül, Ümit and Aslan, Esma and Günalp, Aybüke and Haşlak, Fatih and Yıldız, Mehmet and Adroviç, Amra and Şahin, Sezgin and Barut, Kenan and Kasapçopur, Özgür},
title = {Familial aggregation rate of psoriasis in pediatric rheumatic diseases: A tertiary center cross-sectional study and insights into shared autoimmune pathways},
journal = {Trends in Pediatrics},
year = {2026},
volume = {7},
number = {2},
pages = {129--136},
doi = {10.59213/tp.2026.411}
}
EUVIMED